Haibo Xie

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Venues

Journal of medicinal chemistry

University of Wisconsin–Madison

Shanghai Institute of Organic Chemistry (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Wisconsin–Madison Jan 01 2019

United States

assistant scientist :: School of Pharmacy

University of Wisconsin–Madison Sep 01 2015 - Dec 31 2018

United States

postdoc/research associate :: School of Pharmacy

Simon Fraser University Jul 23 2012 - Aug 30 2015

Canada

postdoc/research associate :: Chemistry

Education History

Shanghai Institute of Organic Chemistry Sep 01 2005 - Mar 01 2011

China

PHD

Publications

Haibo Xie, Megan S Bacabac, Min Ma, Eui-Jun Kim, Yidan Wang, Wenxin Wu, Lingjun Li, Wei Xu, Weiping Tang
Development of Potent and Selective Coactivator-Associated Arginine Methyltransferase 1 (CARM1) Degraders. Journal of medicinal chemistry (2023)
Haibo Xie, Chunrong Li, Hua Tang, Ira Tandon, Junzhuo Liao, Brett L Roberts, Yu Zhao, Weiping Tang
Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation. Journal of medicinal chemistry 66 (4) (2023)
Haibo Xie, Chunrong Li, Hua Tang, Ira Tandon, Junzhuo Liao, Brett L Roberts, Yu Zhao, Weiping Tang
Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation. Journal of medicinal chemistry 66 (4) (2023)
Haibo Xie, Chunrong Li, Hua Tang, Ira Tandon, Junzhuo Liao, Brett L Roberts, Yu Zhao, Weiping Tang
Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation. Journal of medicinal chemistry (2023)
Haibo Xie, Chunrong Li, Hua Tang, Ira Tandon, Junzhuo Liao, Brett L Roberts, Yu Zhao, Weiping Tang
Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation. Journal of medicinal chemistry 66 (4) (2023)
Haibo Xie, Chunrong Li, Hua Tang, Ira Tandon, Junzhuo Liao, Brett L Roberts, Yu Zhao, Weiping Tang
Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation. Journal of medicinal chemistry 66 (4) (2023)
Haibo Xie, Gang Chen, Robert N Young
Design, Synthesis, and Pharmacokinetics of a Bone-Targeting Dual-Action Prodrug for the Treatment of Osteoporosis. Journal of medicinal chemistry 60 (16) (2017)

Haibo Xie.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Haibo Xie